{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:41:49Z","timestamp":1789756909689,"version":"4.0.1"},"reference-count":186,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminarsinnuclearmedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1053\/j.semnuclmed.2014.10.001","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T03:02:04Z","timestamp":1424401324000},"page":"136-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Hypoxia Imaging in Gliomas With 18F-Fluoromisonidazole PET: Toward Clinical Translation"],"prefix":"10.1053","volume":"45","author":[{"given":"Christopher","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Dowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Puttick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaniv","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2014.10.001_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.bjc.6600021","article-title":"Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy","volume":"86","author":"Swanson","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.seminoncol.2003.11.031","article-title":"Factors influencing survival in high-grade gliomas","volume":"30","author":"Buckner","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","article-title":"Recursive partitioning analysis of prognostic factors in Three Radiation Therapy Oncology Group malignant glioma trials","volume":"85","author":"Curran","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJM200101113440207","article-title":"Brain tumors","volume":"344","author":"DeAngelis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0140-6736(03)12328-8","article-title":"Primary brain tumours in adults","volume":"361","author":"Behin","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(07)70384-4","article-title":"Nomograms for predicting survival of patients with newly diagnosed glioblastoma: Prognostic factor analysis of EORTC and NCIC trial 26981-22981\/Ce.3","volume":"9","author":"Gorlia","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3171\/jns.2003.99.3.0467","article-title":"Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project","volume":"99","author":"Laws","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","article-title":"Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery","volume":"303","author":"Walker","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clineuro.2011.02.001","article-title":"Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy","volume":"113","author":"Kim","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib12","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.20.6.1635","article-title":"Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy","volume":"20","author":"Chan","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib13","first-page":"173","article-title":"New PET radiopharmaceuticals beyond FDG for brain tumor imaging","volume":"56","author":"Gulyas","year":"2012","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","article-title":"Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck","volume":"38","author":"Brizel","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0360-3016(88)90002-8","article-title":"Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy","volume":"14","author":"Gatenby","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365516809168210","article-title":"Intercapillary distance, oxygen tension and local recurrence in cervix cancer","volume":"106","author":"Kolstad","year":"1968","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrc925","article-title":"Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy?","volume":"2","author":"Rafii","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc3007","article-title":"Strategies to improve radiotherapy with targeted drugs","volume":"11","author":"Begg","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1172\/JCI40283","article-title":"Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice","volume":"120","author":"Kioi","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib20","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1172\/JCI42345","article-title":"Resisting arrest: A switch from angiogenesis to vasculogenesis in recurrent malignant gliomas","volume":"120","author":"Greenfield","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/stem.318","article-title":"Radiation resistance of cancer stem cells: the 4 R\u2019s of radiobiology revisited","volume":"28","author":"Pajonk","year":"2010","journal-title":"Stem Cells"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/2191-219X-3-49","article-title":"Automated computer quantification of breast cancer in small-animal models using PET-guided MR Image co-segmentation","volume":"3","author":"Bagci","year":"2013","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib24","first-page":"407","article-title":"Differentiating recurrent tumor from radiation necrosis: Time for re-evaluation of positron emission tomography?","volume":"19","author":"Ricci","year":"1998","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib26","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib27","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature06489","article-title":"Identification of cells initiating human melanomas","volume":"451","author":"Schatton","year":"2008","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1982","article-title":"Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy","volume":"10","author":"Fillmore","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib31","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/jnci\/djj495","article-title":"The response of CD24(\u2212\/low)\/CD44+ breast cancer-initiating cells to radiation","volume":"98","author":"Phillips","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1073\/pnas.0606599104","article-title":"WNT\/beta-catenin mediates radiation resistance of mouse mammary progenitor cells","volume":"104","author":"Woodward","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbrc.2009.01.040","article-title":"Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SIRT1 expression","volume":"380","author":"Chang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib35","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.cdd.4401872","article-title":"Chemotherapy resistance of glioblastoma stem cells","volume":"13","author":"Eramo","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ijc.24402","article-title":"The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells","volume":"125","author":"Lomonaco","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002090","article-title":"Identification of CD133-positive radioresistant cells in atypical teratoid\/rhabdoid tumor","volume":"3","author":"Chiou","year":"2008","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib38","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2174\/1871527311201070878","article-title":"Angiogenesis and hypoxia in glioblastoma: A focus on cancer stem cells","volume":"11","author":"Mongiardi","year":"2012","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(99)00102-4","article-title":"Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome","volume":"53","author":"Brizel","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","article-title":"What is the evidence that tumors are angiogenesis dependent?","volume":"82","author":"Folkman","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/gyno.1993.1262","article-title":"Tumor oxygenation: A new predictive parameter in locally advanced cancer of the uterine cervix","volume":"51","author":"Hockel","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/bjc.1955.55","article-title":"The histological structure of some human lung cancers and the possible implications for radiotherapy","volume":"9","author":"Thomlinson","year":"1955","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0360-3016(94)90432-4","article-title":"Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors","volume":"29","author":"Rampling","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib45","series-title":"Radiobiology for the Radiologist (ed 4)","year":"1994"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib46","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.dnarep.2007.02.006","article-title":"DNA double-strand break repair: From mechanistic understanding to cancer treatment","volume":"6","author":"Helleday","year":"2007","journal-title":"DNA Repair (Amst)"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2011.07.001","article-title":"Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours","volume":"100","author":"Menegakis","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib48","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139","volume":"273","author":"Rogakou","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib49","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10555-006-9009-z","article-title":"Advances in methods for assessing tumor hypoxia in vivo: Implications for treatment planning","volume":"25","author":"Davda","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib50","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1158\/1078-0432.CCR-04-1081","article-title":"Hypoxia is important in the biology and aggression of human glial brain tumors","volume":"10","author":"Evans","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib51","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1158\/0008-5472.CAN-03-2424","article-title":"Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding","volume":"64","author":"Evans","year":"2004","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-8140(93)90025-4","article-title":"Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix","volume":"26","author":"Hockel","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib53","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0360-3016(00)01493-0","article-title":"Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma","volume":"49","author":"Nordsmark","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-8140(00)00223-1","article-title":"A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy","volume":"57","author":"Nordsmark","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(98)00123-6","article-title":"Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations","volume":"50","author":"Powell","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib56","first-page":"1432","article-title":"[11C]Methionine PET, histopathology, and survival in primary brain tumors and recurrence","volume":"27","author":"Ceyssens","year":"2006","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib57","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1126\/science.3420417","article-title":"Imaging of phosphorescence: A novel method for measuring oxygen distribution in perfused tissue","volume":"241","author":"Rumsey","year":"1988","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4615-0205-0_30","article-title":"Oxygen distributions in tissue measured by phosphorescence quenching","volume":"510","author":"Vinogradov","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib59","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1158\/0008-5472.CAN-09-3948","article-title":"Phosphorescent light-emitting iridium complexes serve as a hypoxia-sensing probe for tumor imaging in living animals","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.mibio.2004.06.007","article-title":"Functional imaging of intratumoral hypoxia","volume":"6","author":"Foo","year":"2004","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tibtech.2010.04.002","article-title":"(19)F MRI for quantitative in vivo cell tracking","volume":"28","author":"Srinivas","year":"2010","journal-title":"Trends Biotechnol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib62","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.1840180426","article-title":"Quantitative detection of hemoglobin saturation in the liver with near-infrared spectroscopy","volume":"18","author":"Kitai","year":"1993","journal-title":"Hepatology"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib63","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/sj.bjc.6690272","article-title":"Carbogen-induced changes in rat mammary tumour oxygenation reported by near infrared spectroscopy","volume":"79","author":"Hull","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib64","first-page":"452","article-title":"Monitoring of cerebral O2 sufficiency, blood volume, HbO2-Hb shifts and bloodflow","volume":"64","author":"Jobsis","year":"1977","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib65","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejvs.2009.07.008","article-title":"The value of near-infrared spectroscopy measured cerebral oximetry during carotid endarterectomy in perioperative stroke prevention; A review","volume":"38","author":"Pennekamp","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib66","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM197912273012606","article-title":"Hypoxic sensitizers\u2014Implications for radiation therapy","volume":"301","author":"Chapman","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib67","first-page":"1653","article-title":"On measuring hypoxia in individual tumors with radiolabeled agents","volume":"42","author":"Chapman","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib68","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(96)00325-2","article-title":"Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients","volume":"36","author":"Rasey","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0360-3016(92)91001-4","article-title":"Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole","volume":"22","author":"Koh","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib70","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00330-006-0431-y","article-title":"Imaging oxygenation of human tumours","volume":"17","author":"Padhani","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2967\/jnumed.108.055467","article-title":"Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas","volume":"50","author":"Swanson","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib72","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2307\/3577760","article-title":"Characteristics of the binding of labeled fluoromisonidazole in cells in vitro","volume":"122","author":"Rasey","year":"1990","journal-title":"Radiat Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib73","first-page":"410","article-title":"Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18f-FDG PET, and immunohistochemical studies","volume":"47","author":"Cher","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib74","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00259-010-1645-4","article-title":"Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma","volume":"38","author":"Kawai","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib75","first-page":"2133","article-title":"Hypoxia in human gliomas: Demonstration by PET with fluorine-18-fluoromisonidazole","volume":"33","author":"Valk","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib76","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/MNM.0b013e3283529984","article-title":"Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas","volume":"33","author":"Yamamoto","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.semnuclmed.2007.07.001","article-title":"Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole","volume":"37","author":"Lee","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2307\/3576542","article-title":"Iodoazomycin riboside (1-(5\u2019-iodo-5\u2019-deoxyribofuranosyl)-2-nitroimidazole), a hypoxic cell marker. I. synthesis and in vitro characterization","volume":"105","author":"Jette","year":"1986","journal-title":"Radiat Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib79","first-page":"1764","article-title":"Radioiodinated 1-(5-Iodo-5-Deoxy-Beta-d-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): A novel marker of tissue hypoxia","volume":"32","author":"Mannan","year":"1991","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib80","first-page":"60","article-title":"Radioiodinated azomycin pyranoside (IAZP): A novel non-invasive marker for the assessment of tumor hypoxia","volume":"36","author":"Mannan","year":"1992","journal-title":"J Nucl Biol Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib81","first-page":"995","article-title":"Potential applications of PET imaging in developing novel cancer therapies","volume":"40","author":"Hustinx","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib82","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0969-8051(02)00442-0","article-title":"[18F]fluoroazomycinarabinofuranoside (18FAZA) and [18F]fluoromisonidazole (18FMISO): A comparative study of their selective uptake in hypoxic cells and pet imaging in experimental rat tumors","volume":"30","author":"Sorger","year":"2003","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib83","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s00259-010-1517-y","article-title":"Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma","volume":"37","author":"Koch","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib84","first-page":"1072","article-title":"Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia","volume":"40","author":"Rasey","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib85","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0883-2889(89)90186-X","article-title":"No-carrier-added synthesis of 3-[18F]fluoro-1-(2-nitro-1-imidazolyl)-2-propanol. A potential PET agent for detecting hypoxic but viable tissues","volume":"40","author":"Hwang","year":"1989","journal-title":"Int J Rad Appl Instrum A"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib86","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0969-8043(99)00096-2","article-title":"Synthesis of new hypoxia markers EF1 and [18F]-EF1","volume":"51","author":"Kachur","year":"1999","journal-title":"Appl Radiat Isot"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib87","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/1099-1344(200007)43:8<785::AID-JLCR363>3.0.CO;2-5","article-title":"Synthesis of 1-[2-[18F]fluoro-1-(hydroxymethyl)-ethoxy]methyl-2-nitroimidazole ([18F]FENI), a potential agent for imaging hypoxic tissues by PET","volume":"43","author":"Wada","year":"2000","journal-title":"J Labelled Compounds Radiopharm"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib88","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.194.3.7862981","article-title":"Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia","volume":"194","author":"Yang","year":"1995","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib89","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MNM.0b013e32834eacb7","article-title":"Hypoxia imaging with PET: Which tracers and why?","volume":"33","author":"Chia","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib90","unstructured":"Rajendran JG, Krohn KA: Imaging Tumour Hypoxia, in (eds): (ed). London, Springer-Verlag, 2002"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib91","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1158\/1078-0432.CCR-07-4995","article-title":"Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: Correlation with time to progression and survival","volume":"14","author":"Spence","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib92","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/1078-0432.CCR-0688-3","article-title":"Hypoxia and glucose metabolism in malignant tumors: Evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging","volume":"10","author":"Rajendran","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib93","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1158\/0008-5472.CAN-08-3884","article-title":"Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas","volume":"69","author":"Szeto","year":"2009","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib94","first-page":"781","article-title":"Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model","volume":"38","author":"Valable","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib95","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1667\/0033-7587(2000)153[0084:DHFIAR]2.0.CO;2","article-title":"Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole","volume":"153","author":"Rasey","year":"2000","journal-title":"Radiat Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib96","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jmri.22263","article-title":"Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography","volume":"32","author":"Doblas","year":"2010","journal-title":"J Magn Reson Imaging"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib97","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/nbm.1278","article-title":"Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: A longitudinal in vivo and ex vivo study","volume":"21","author":"Valable","year":"2008","journal-title":"NMR Biomed"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib98","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11060-009-9875-7","article-title":"Rat brain tumor models in experimental neuro-oncology: The C6, 9l, T9, Rg2, F98, BT4c, RT-2 and CNS-1 gliomas","volume":"94","author":"Barth","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib99","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/hsz-2012-0318","article-title":"Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): A PET study in two experimental models of human glioma","volume":"394","author":"Corroyer-Dulmont","year":"2013","journal-title":"Biol Chem"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ijrobp.2005.09.010","article-title":"A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker","volume":"64","author":"Kleiter","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib101","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0969-8051(01)00298-0","article-title":"Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO)","volume":"29","author":"Tochon-Danguy","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib102","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1474-4422(10)70181-2","article-title":"Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas","volume":"9","author":"Dhermain","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib103","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology Working Group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib104","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00259-009-1219-5","article-title":"Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme","volume":"37","author":"Galldiks","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1006436624862","article-title":"Growth factors in glioma angiogenesis: Fgfs, PDGF, EGF, and TGFS","volume":"50","author":"Dunn","year":"2000","journal-title":"J Neurooncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib106","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1750-3639.2005.tb00115.x","article-title":"Angiogenesis in gliomas: Biology and molecular pathophysiology","volume":"15","author":"Fischer","year":"2005","journal-title":"Brain Pathol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib107","unstructured":"Swanson KR: Methematical Modeling of the Growth and Control of Tumours. 1999"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2003.06.001","article-title":"Virtual and real brain tumors: Using mathematical modeling to quantify glioma growth and invasion","volume":"216","author":"Swanson","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib109","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bjc.6604125","article-title":"A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: A proof of principle","volume":"98","author":"Swanson","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.20.2.379","article-title":"Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography","volume":"20","author":"Bos","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib111","first-page":"502","article-title":"Effects of hypoxia on the uptake of tritiated thymidine, l-leucine, l-methionine and FDG in cultured cancer cells","volume":"37","author":"Clavo","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib112","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00000421-200110000-00011","article-title":"Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation","volume":"24","author":"Evans","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib113","first-page":"440","article-title":"Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: Analysis of the FDG lumped constant","volume":"39","author":"Spence","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib114","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00259-002-1096-7","article-title":"[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: Correlation of hypoxia, metabolism and VEGF expression","volume":"30","author":"Rajendran","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.nucmedbio.2008.06.001","article-title":"Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer","volume":"35","author":"Dence","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib116","first-page":"945","article-title":"Imaging proliferation in brain tumors with 18f-FLT PET: Comparison with 18f-FDG","volume":"46","author":"Chen","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib117","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/3337","article-title":"Imaging proliferation in vivo with [F-18]FLT and positron emission tomography","volume":"4","author":"Shields","year":"1998","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib118","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2967\/jnumed.107.048520","article-title":"Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone)","volume":"49","author":"Dehdashti","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib119","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0360-3016(02)04477-2","article-title":"Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60cu-ATSM: Relationship to therapeutic response\u2014A preliminary report","volume":"55","author":"Dehdashti","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00259-003-1130-4","article-title":"In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM","volume":"30","author":"Dehdashti","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib121","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s10350-008-9420-3","article-title":"Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: A pilot study","volume":"51","author":"Dietz","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib122","first-page":"1155","article-title":"Copper-62-ATSM: A new hypoxia imaging agent with high membrane permeability and low redox potential","volume":"38","author":"Fujibayashi","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib123","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1039\/b705989b","article-title":"Cu-ATSM: A radiopharmaceutical for the pet imaging of hypoxia","author":"Vavere","year":"2007","journal-title":"Dalton Trans"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib124","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3892\/ijo.2013.1781","article-title":"Biological characteristics of intratumoral [F-18]fluoromisonidazole distribution in a rodent model of glioma","volume":"42","author":"Hatano","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib125","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1097\/RLU.0b013e3182335e20","article-title":"Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma","volume":"36","author":"De Clermont","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib126","first-page":"867","article-title":"Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67","volume":"138","author":"Gerdes","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib127","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01806492","article-title":"Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas","volume":"37","author":"Haerslev","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib128","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1440-1827.1996.tb03574.x","article-title":"Proliferation marker Mib-1 correlates well with Proliferative Activity Evaluated by Brdu in Breast Cancer: An Immunohistochemical Study Including Correlation with Pcna, P53, C-Erbb-2 and Estrogen Receptor Status","volume":"46","author":"Moriki","year":"1996","journal-title":"Pathol Int"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: From the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0169-328X(94)90183-X","article-title":"Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors","volume":"27","author":"Boado","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib131","first-page":"348","article-title":"Mammalian glucose transporters: Structure and molecular regulation","volume":"47","author":"Burant","year":"1991","journal-title":"Recent Prog Horm Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib132","first-page":"3972","article-title":"Distribution of the glucose transporters in human brain tumors","volume":"52","author":"Nishioka","year":"1992","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib133","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-291X(90)91263-R","article-title":"Over-expression of facilitative glucose transporter genes in human cancer","volume":"170","author":"Yamamoto","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib134","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1711770310","article-title":"Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, chalkley count, and computer image analysis","volume":"177","author":"Fox","year":"1995","journal-title":"J Pathol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib135","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.bjc.6600315","article-title":"Intra-tumoural microvessel density in human solid tumours","volume":"86","author":"Hasan","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib136","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<130::AID-PATH19>3.0.CO;2-W","article-title":"Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: A multiparametric and immunohistochemical analysis","volume":"184","author":"Jacquemier","year":"1998","journal-title":"J Pathol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib137","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0090-4295(98)00561-5","article-title":"Microvessel density in prostate cancer: Lack of correlation with tumor grade, pathologic stage, and clinical outcome","volume":"53","author":"Rubin","year":"1999","journal-title":"Urology"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis\u2014Correlation in invasive breast carcinoma","volume":"324","author":"Weidner","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib139","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000065201","article-title":"From erythropoietin to oxygen: Hypoxia-inducible factor hydroxylases and the hypoxia signal pathway","volume":"20","author":"Ratcliffe","year":"2002","journal-title":"Blood Purif"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/320084a0","article-title":"Localization of gene for human P53 tumour antigen to band 17p13","volume":"320","author":"Isobe","year":"1986","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib141","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1126\/science.2047879","article-title":"Identification of p53 as a sequence-specific DNA-binding protein","volume":"252","author":"Kern","year":"1991","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib142","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/j.1460-2075.1984.tb02287.x","article-title":"Isolation and characterization of a human p53 cDNA clone: Expression of the human p53 gene","volume":"3","author":"Matlashewski","year":"1984","journal-title":"EMBO J"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib143","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1073\/pnas.83.1.130","article-title":"The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13)","volume":"83","author":"McBride","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib144","first-page":"1637","article-title":"Gliomas: Correlation of histologic grade, Ki67 and P53 expression with patient survival","volume":"11","author":"Arshad","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11307-007-0095-2","article-title":"Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix","volume":"9","author":"Grigsby","year":"2007","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib146","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1215\/S1152851704001115","article-title":"Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis","volume":"7","author":"Kaur","year":"2005","journal-title":"Neuro Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib147","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1007\/s00259-014-2776-9","article-title":"Correlation between F-fluoromisonidazole PET and expression of HIF-1alpha and VEGF in newly diagnosed and recurrent malignant gliomas","volume":"41","author":"Kawai","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib148","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1200\/JCO.20.3.680","article-title":"Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer","volume":"20","author":"Fyles","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib149","first-page":"4509","article-title":"Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix","volume":"56","author":"Hockel","year":"1996","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-8140(99)00139-5","article-title":"Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix","volume":"53","author":"Knocke","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib151","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0167-8140(99)00175-9","article-title":"Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization","volume":"54","author":"Sundfor","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib152","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0360-3016(01)01523-1","article-title":"Tumor hypoxia, p53, and prognosis in cervical cancers","volume":"50","author":"Haensgen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib153","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1054\/bjoc.2000.1266","article-title":"Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis","volume":"83","author":"Rofstad","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib154","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0167-8140(00)00200-0","article-title":"Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer","volume":"57","author":"Rudat","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib155","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000064313","article-title":"Prognostic factors in squamous cell carcinoma of the head and neck","volume":"25","author":"Wendt","year":"2002","journal-title":"Onkologie"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib156","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/jjco\/hyr181","article-title":"Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: Changes defined by 18f-fluoromisonidazole positron emission tomography: Two case reports","volume":"42","author":"Narita","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib157","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1215\/15228517-2007-024","article-title":"Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma","volume":"9","author":"de Bouard","year":"2007","journal-title":"Neuro Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib158","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1227\/01.NEU.0000129551.64651.74","article-title":"PTK787\/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization","volume":"55","author":"Goldbrunner","year":"2004","journal-title":"Neurosurgery"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib159","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo","volume":"362","author":"Kim","year":"1993","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib160","first-page":"6624","article-title":"Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2","volume":"61","author":"Kunkel","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib161","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/14728220902806444","article-title":"Anti-VEGF therapies for malignant glioma: Treatment effects and escape mechanisms","volume":"13","author":"Miletic","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib162","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1476-5586(03)80023-4","article-title":"Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy","volume":"5","author":"Ran","year":"2003","journal-title":"Neoplasia"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib163","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.neo.7900102","article-title":"Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption","volume":"2","author":"Rubenstein","year":"2000","journal-title":"Neoplasia"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib164","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/sj.bjc.6602108","article-title":"The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model","volume":"91","author":"Sandstrom","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib165","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/1471-2407-9-444","article-title":"Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme","volume":"9","author":"Verhoeff","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib166","doi-asserted-by":"crossref","first-page":"251231","DOI":"10.1155\/2010\/251231","article-title":"Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma","volume":"2010","author":"Rahman","year":"2010","journal-title":"J Oncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib167","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib168","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/cncr.23678","article-title":"Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme","volume":"113","author":"Flynn","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib169","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00130404-200611000-00005","article-title":"The interactions of polarographic measurements of oxygen tension and histological grade in human glioma","volume":"12","author":"Lally","year":"2006","journal-title":"Cancer J"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1874467210902030263","article-title":"Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy","volume":"2","author":"Oliver","year":"2009","journal-title":"Curr Mol Pharmacol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib171","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3171\/jns.1986.65.4.0476","article-title":"A proposed grading system for arteriovenous malformations","volume":"65","author":"Spetzler","year":"1986","journal-title":"J Neurosurg"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib172","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1006167412835","article-title":"Extent of resection in malignant gliomas: A critical summary","volume":"42","author":"Sawaya","year":"1999","journal-title":"J Neurooncol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib173","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(02)08091-1","article-title":"Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials","volume":"359","author":"Stewart","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib174","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00259-011-2037-0","article-title":"(1)(8)F-fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas","volume":"39","author":"Hirata","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib175","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1088\/0031-9155\/50\/10\/002","article-title":"A kinetic model for dynamic [18F]-FMISO PET data to analyse tumour hypoxia","volume":"50","author":"Thorwarth","year":"2005","journal-title":"Phys Med Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib176","first-page":"1851","article-title":"Assessment of hypoxia and perfusion in human brain tumors using pet with 18F-fluoromisonidazole and 15O-H2O","volume":"45","author":"Bruehlmeier","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib177","first-page":"816","article-title":"An investigation of a double-tracer technique for positron computerized tomography","volume":"23","author":"Huang","year":"1982","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib178","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1088\/0031-9155\/56\/14\/020","article-title":"Dual-isotope PET using positron-gamma emitters","volume":"56","author":"Andreyev","year":"2011","journal-title":"Phys Med Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib179","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1109\/TNS.2009.2026417","article-title":"Rapid multi-tracer PET tumor imaging with F-FDG and secondary shorter-lived tracers","volume":"56","author":"Black","year":"2009","journal-title":"IEEE Trans Nucl Sci"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib180","doi-asserted-by":"crossref","unstructured":"Cheng X, Navab N, Ziegler S, et al: Direct Parametric Image Reconstruction of Rapid Multi-Tracer PET, in (eds): (ed), Berlin, Heidelberg, Springer, 2013","DOI":"10.1007\/978-3-642-40760-4_20"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib181","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/978-3-642-02498-6_4","article-title":"Dynamic dual-tracer PET reconstruction","volume":"21","author":"Gao","year":"2009","journal-title":"Inf Process Med Imaging"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib182","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1109\/TNS.2005.858230","article-title":"Feasibility of rapid multitracer PET tumor imaging","volume":"52","author":"Kadrmas","year":"2005","journal-title":"IEEE Transactions on Nucl Sci"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib183","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1088\/0031-9155\/58\/3\/429","article-title":"Single-scan dual-tracer FLT+FDG PET tumor characterization","volume":"58","author":"Kadrmas","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib184","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.107.044966","article-title":"A multicenter clinical trial on the diagnostic value of dual-tracer PET\/CT in pulmonary lesions using 3\u2019-deoxy-3\u2019-18F-fluorothymidine and 18F-FDG","volume":"49","author":"Tian","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib185","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1088\/0031-9155\/59\/14\/3925","article-title":"Dual acquisition of 18F-FMISO and 18F-FDOPA","volume":"59","author":"Bell","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1053\/j.semnuclmed.2014.10.001_bib186","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2006.07.023","article-title":"Imaging hypoxia after oxygenation-modification: Comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors","volume":"80","author":"Troost","year":"2006","journal-title":"Radiother Oncol"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299814001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299814001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T03:16:50Z","timestamp":1566357410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299814001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":186,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0001299814001196"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2014.10.001","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia Imaging in Gliomas With 18F-Fluoromisonidazole PET: Toward Clinical Translation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}